Mount Sinai Health System · 5 months ago
Neuropsychology - Mount Sinai Corinne Goldsmith Dickinson Center for Multiple Sclerosis - Manhattan, NY
Mount Sinai Health System is a leading academic medical center seeking a full-time Neuropsychologist specializing in Multiple Sclerosis and Neuroinflammatory Diseases. The role involves conducting comprehensive neuropsychological evaluations, providing outpatient assessments, and collaborating with interdisciplinary teams to enhance patient care and engage in research initiatives.
Health CareHospitalMedical
Responsibilities
The neuropsychologist will participate in our multidisciplinary case conferences, presenting assessment findings and contributing to patient care planning
There will also be opportunities to engage in research, including investigations into cognitive and neurological functioning, disease mechanisms, and clinical interventions
Collaboration with interdisciplinary teams is encouraged, with access to resources and support for developing independent research initiatives
Qualification
Required
Eligible for appointment as Assistant Professor
Ph.D. or Psy.D. required from an APA or CPA-accredited program in Clinical or Counseling Psychology or a related field
Current New York State licensure required
Post-doctoral training in Neuropsychology is required
Preferred
Board-certified or Board-eligible in Clinical Neuropsychology
Benefits
Competitive salary and benefits package
Company
Mount Sinai Health System
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.
H1B Sponsorship
Mount Sinai Health System has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageTotal Funding
$41.9MKey Investors
National Institutes of HealthHearst Health Prize.Multiple Myeloma Research Foundation
2024-11-11Grant· $7M
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M
Leadership Team
Recent News
Digital Journal
2026-01-08
Company data provided by crunchbase